Navigation Links
Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures
Date:7/15/2009

l products and our anticipated new product introductions; the highly regulated nature of our business; product liability, intellectual property and other litigation risks and environmental liabilities; the outcome of government investigations; uncertainty regarding our intellectual property rights and those of others; difficulties associated with, and regulatory compliance with respect to, manufacturing of our products; risks associated with our strategic relationships; global economic conditions; interest and currency exchange rate fluctuations and volatility in the credit and financial markets; changes in generally accepted accounting principles; trade buying patterns; the impact of legislation and regulatory compliance; risks and uncertainties associated with global operations and sales; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "Item 1A, Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission (SEC) on February 27, 2009. The forward-looking statements in this press release are qualified by these risk factors. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.


'/>"/>
SOURCE Wyeth
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Wyeth Consumer Healthcare Announces the Availability of New Centrum Ultra Line of Multivitamins Specially Formulated For Women and Men
2. Wyeths Prevenar 13* Receives First Approval
3. Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
4. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
5. New Therapies, Including Novel Biologic Agents from Elan/Wyeth and Eli Lilly, Will Drive Robust 11 Percent Annual Growth In the Alzheimers Disease Market
6. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
7. DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza
8. Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
9. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
10. Wyeth Reports Earnings Results for the 2009 First Quarter
11. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...rdan Fiddle Foundation, a national autism organiza...d support programs and services for adolescents an... released a free informational brochure entitled &...gnize The Signs and Basic First Aid When You Do.&q...B) December 1, 2009 -- Statistics show that as man...
(Date:12/1/2009)...re/ -- What many spa clients have thought for year... proclaimed in the 2009 AsiaSpa Awards: Thailand i...tations including "Asian Spa Capital of the Year",...AsiaSpa Awards, presented by AsiaSpa magazine, the...tion, during a glittering ceremony recently in Hon...
(Date:12/1/2009)...he annual meeting of the Radiological Society of N...accurate means of identifying placenta accreta, a ...on condition that is the leading cause of death fo...Due to the increase in cesarean sections and other..., coupled with women giving birth later in life, t...
(Date:12/1/2009)...could lead to early degeneration in the spine, acc...eting of the Radiological Society of North America...ssociation between increased body mass index (BMI)...dy,s lead author, Judah G. Burns, M.D., fellow in ...al at Montefiore in New York City. , In this re...
(Date:11/30/2009).../ -- Being overweight as a child could lead to ear... presented today at the annual meeting of the Radi...his is the first study to show an association betw...malities in children," said the study,s lead autho...oradiology at The Children,s Hospital at Montefior...
Breaking Medicine News(10 mins):Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 2Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 3Health News:Daniel Jordan Fiddle Foundation for Adults with Autism Offers Free Epilepsy First-Aid Brochure 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 2Health News:Thailand - Spa Capital of Asia by Karen Emmons 3Health News:Thailand - Spa Capital of Asia by Karen Emmons 4Health News:Thailand - Spa Capital of Asia by Karen Emmons 5Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:Overweight Children may Develop Back Pain and Spinal Abnormalities 2
...tration, Evaluation and Authorization of Chemicals...ling safe chemicals to the// manufacturers. ...ke use of only safe chemicals for safety of thei...iament has approved this legislation on the use of...
...rst ever "five-star" hospital, which has seen mass... Day. // Half of the rooms of the "five-star...others and babies, have been reserved. Traditional...ulnerable to evil spirits during this period. ...
...e loss of central vision has shown promise in stem... which involves the same central// light-sensitive...e scientists report. Encouraged by the effe...cular edema, one of many complications of diabetes...
...air. To tackle obesity in school children, and inc...posal to include yoga in the// school curriculum w...l from the HRD ministry. While announcing th...chers who would take yoga classes. We will also st...
...ate (BBIC) is a natural soy-based substance. A US ...animals with a disease similar to multiple// scler...ephalomyelitis (EAE) received BBIC, while another ... get the drug were not," said the study leader Dr....
...including enlarged or painful breast tissue, but t...rs from Mayo Clinic Cancer Center. // Mammograms a...s, which are very rare in males. Their study,...s for men, who are most often diagnosed with non-c...
Other Medicine News:Health News:Drug Treatment Slows Macular Vision Loss in Diabetics 2Health News:Use of Mammograms in Men 2
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Cardiac Defibr... ,, http://www.reportlinker.com/p0164315/Cardi...e-Report.html ,, Cardiovascular disease (CVD).... Sudden cardiac arrest survivors are prone to arr...
(Date:11/30/2009)..., NEW YORK, Nov. 30 Reportlinker.... available in its catalogue: ,, Outsourcing Op..., http://www.reportlinker.com/p0165747/Outsour..., Report Description ,, Medical devices form ... with an estimated size of $250 billion in 2009 an...
(Date:11/30/2009)...VINA, Calif., Nov. 30 StemCyte, In...ation agreement with Academia Sinica, the National...hods and Intellectual Property (IP) related to the...s method and IP was pioneered by a team led by Pro...inica. Professor Lin is currently the exclusive c...
Breaking Medicine Technology:Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 1Senators Kohl and Feingold Vote to Protect Americas Kids From Tobacco 48691 2Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 1Senators Baucus and Tester Vote to Protect Americas Kids From Tobacco 48688 2Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 1Senators Levin and Stabenow Vote to Protect Americas Kids from Tobacco 48685 2
...Apr 11, 2007 - A comparison of,the long-term econo...es combined with symptom management versus symptom...ramer acetate,injection) was the most cost-effecti...iple sclerosis (RRMS). The study provides,the firs...eness of,multiple sclerosis (MS) therapies that in...
...Apr 11, 2007 - Gloucester,Pharmaceuticals, Inc., a...unced today that several abstracts covering,precli...e 2007,Annual Meeting of the American Association ... April 14-18, 2007. These,presentations will focus... multiple academic collaborators of the Company. F...
Other Medicine Technology:First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 2First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 3First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 4First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 5First Pharmacoeconomic Analysis with Long-Term Data Showed Copaxone,Was More Cost-Effective Than Interferon Beta Therapies for,Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) 6Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 2Gloucester Pharmaceuticals Announces Multiple Presentations of,Preclinical Romidepsin Data at American Association of Cancer,Research Annual Meeting 3
NitEye The Dry Eye Comforter
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
...tronic Ophthalmics offers the most comprehensive f... Instruments for Cataract incision, Glaucoma filtr...te coagulation is achieved with minimal tissue tra...ight eraser styles are available in 18, 20, and 20...
Medicine Products: